Adaptimmune Therapeutics (ADAP)
(Delayed Data from NSDQ)
$1.24 USD
+0.09 (7.83%)
Updated May 15, 2024 04:00 PM ET
After-Market: $1.23 -0.01 (-0.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: BMO |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Adaptimmune Therapeutics (ADAP) reported earnings of -$0.18 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 12.50%. Look out for ADAP's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 1700%.
Earnings History
Price & Consensus
Zacks News for ADAP
Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know
ADAP: What are Zacks experts saying now?
Zacks Private Portfolio Services